SciSparc Ltd: This Innovative Biotech May Have a 3.5x Upside
Meet SciSparc Ltd., the biotech disruptor with potential pipeline revenues of about $490,926,545
Meet SciSparc Ltd., the biotech disruptor with potential pipeline revenues of about $490,926,545
The winner will be chosen from the stage at The North American Bitcoin Conference
With largest international presence at the show, U.S. looks to advance a new century of cooperation with Chile.
The rider will lift animal-testing mandate under federal law and drive use of alternatives
Effort aims to widen access to NASA earth science data for geospatial intelligence and accelerate climate-related discoveries
Nuvectis Chairman & CEO Ron Bentsur: “2024 is shaping up to be a potentially transformational year for Nuvectis with several clinical data updates expected in the second half of the year.”
OcyonBio CDMO welcomes cell and gene therapy expert Robert Salcedo who brings over 20 years of expertise in the areas of CMC, operations, and supply chain management and has served in multi-billion-dollar companies operating in biotech, vaccines, and pharmaceutical markets.
By Ehime University
